AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENTChange in Control Agreement • May 15th, 2012 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Maryland
Contract Type FiledMay 15th, 2012 Company Industry JurisdictionTHIS AMENDED AND RESTATED CHANGE IN CONTROL AGREEMENT (this “Agreement”) is effective as of April 3 2012, by and between REGENERX BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and DAVID R. CROCKFORD (the “Executive”).